Search research articles
Contact Us
Filters
Showing results (81-90 of 439) with videos related to
Page
of 44
Sort By:
Journal of Hepatology
|
October 13, 2015
Reply to "Statin treatment for non-alcoholic steatohepatitis"
Paola Dongiovanni, Jussi Pihlajamaki, Stefano Romeo, et al.
Expert Opinion on Therapeutic Targets
|
December 14, 2021
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date
Alessandro Cherubini, Elia Casirati, Melissa Tomasi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 7, 2020
COVID-19 and liver disease
Jian Sun, Alessio Aghemo, Alejandro Forner, et al.
Expert Review of Gastroenterology & Hepatology
|
December 8, 2015
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?
Paola Dongiovanni, Raffaela Rametta, Marica Meroni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 9, 2016
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Luca Valenti, Elisabetta Bugianesi, Utpal Pajvani, et al.
Pediatric Transplantation
|
February 23, 2019
Post-transplant metabolic syndrome in children: Know better to cure better
Valerio Nobili, Andrea Pietrobattista, Luca Valenti, et al.
World Journal of Nephrology
|
November 1, 2013
Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease
Elena Canavesi, Carlo Alfieri, Serena Pelusi, et al.
Journal of Clinical Medicine
|
January 27, 2021
Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders
Cristiana Bianco, Elena Coluccio, Daniele Prati, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 10, 2023
Fatty liver disease genetic risk variants and interference on sex hormones
Federica Tavaglione, Oveis Jamialahmadi, Luca Valenti, et al.
Current Opinion in Pharmacology
|
September 19, 2021
Genetic risk scores and personalization of care in fatty liver disease
Cristiana Bianco, Federica Tavaglione, Stefano Romeo, et al.
Page
of 44
Search research articles
Search
Showing results (81-90 of 439) with videos related to
Sort By:
Page
of 44
Journal of Hepatology
|
October 13, 2015
Reply to "Statin treatment for non-alcoholic steatohepatitis"
Paola Dongiovanni, Jussi Pihlajamaki, Stefano Romeo, et al.
Expert Opinion on Therapeutic Targets
|
December 14, 2021
PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date
Alessandro Cherubini, Elia Casirati, Melissa Tomasi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 7, 2020
COVID-19 and liver disease
Jian Sun, Alessio Aghemo, Alejandro Forner, et al.
Expert Review of Gastroenterology & Hepatology
|
December 8, 2015
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?
Paola Dongiovanni, Raffaela Rametta, Marica Meroni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 9, 2016
Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
Luca Valenti, Elisabetta Bugianesi, Utpal Pajvani, et al.
Pediatric Transplantation
|
February 23, 2019
Post-transplant metabolic syndrome in children: Know better to cure better
Valerio Nobili, Andrea Pietrobattista, Luca Valenti, et al.
World Journal of Nephrology
|
November 1, 2013
Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease
Elena Canavesi, Carlo Alfieri, Serena Pelusi, et al.
Journal of Clinical Medicine
|
January 27, 2021
Diagnosis and Management of Autoimmune Hemolytic Anemia in Patients with Liver and Bowel Disorders
Cristiana Bianco, Elena Coluccio, Daniele Prati, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
May 10, 2023
Fatty liver disease genetic risk variants and interference on sex hormones
Federica Tavaglione, Oveis Jamialahmadi, Luca Valenti, et al.
Current Opinion in Pharmacology
|
September 19, 2021
Genetic risk scores and personalization of care in fatty liver disease
Cristiana Bianco, Federica Tavaglione, Stefano Romeo, et al.
Page
of 44